Composition for Prevention and Treatment of Contact Lens Papillary Conjunctivitis and Allergic Eye Disease

Abstract

The invention provides a use of panthenol or dexpanthenol in the prevention and/or treatment of contact lens papillary conjunctivitis in a subject. A contact lens care solution containing 0.001 to 10% by dry weight dexpanthenol is also provided.

1 - 5 . (canceled) 
     
     
         6 . A contact lens care solution containing 0.001 to 10% by dry weight dexpanthenol. 
     
     
         7 . A contact lens care solution according to  claim 6 , wherein dexpanthenol is present in an amount of 0.01 to 5% by dry weight. 
     
     
         8 . A contact lens care solution according to  claim 7 , wherein dexpanthenol is present in an amount of about 2% by dry weight. 
     
     
         9 . A solution according to  claim 6 , that is aqueous and isotonic. 
     
     
         10 . A solution according to  claim 6 , which Dexpanthenol is the only active component in the solution. 
     
     
         11 . (canceled) 
     
     
         12 . A pharmaceutical composition for treatment of contact lens papillary conjunctivitis or allergic eye disease comprising 0.001 to 10% by dry weight dexpanthenol. 
     
     
         13 . A pharmaceutical composition according to  claim 12 , wherein dexpanthenol is present in an amount of about 2% by dry weight and that is aqueous and isotonic. 
     
     
         14 . A composition according to  claim 12 , which dexpanthenol is the only active in the composition. 
     
     
         15 . A method of making an ophthalmic device for the prevention and/or treatment of contact lens papillary conjunctivitis, by a therapeutically effective amount of dexpanthenol, comprising the step of contacting an ophthalmic device with a solution comprising dexpanthenol and then applying the device to the eye.